Legal Implications Associated with Corporate Medical Department Responses to Pandemics, including H1N1

1 Hour 31 Minutes
SKU: 10ACOEM-2200
Track: Regulary, Legal, Military, and Governmental OEM Practice; Management and Administration in OEM

Robert M. Wolin, JD, Baker Hostetler, Houston, TX

A number of corporate medical departments are beginning to face a significant number of medico-legal issues relating to how they respond to pandemic threats such as the H1N1 virus/bird flu and bioterrorism (e.g. anthrax). This presentation will include the discussion of possible solutions such as distribution agreements with national pharmacy providers, contracts with local health care providers and pharmaceutical supplier distribution and inventory agreements. Additional issues are presented when corporate medical departments attempt to import or export medications for employees outside of the United States.
Product speakers